These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25884457)

  • 1. Optimizing the use of existing therapies in lupus.
    Croyle L; Morand EF
    Int J Rheum Dis; 2015 Feb; 18(2):129-37. PubMed ID: 25884457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
    Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
    Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN; Sanchez FJ; Karim Y; Cuadrado MJ; D'Cruz DP; Abbs IC; Khamasta MA; Hughes GR
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
    Kan H; Nagar S; Patel J; Wallace DJ; Molta C; Chang DJ
    Clin Ther; 2016 Mar; 38(3):610-24. PubMed ID: 26907503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C; Vollenhoven Rv
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
    Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
    Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
    Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
    Feldman CH; Collins J; Zhang Z; Xu C; Subramanian SV; Kawachi I; Solomon DH; Costenbader KH
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1419-1424. PubMed ID: 30354025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS; Reimold AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.